3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
1904
Breast Neoplasms
1423
Carcinoma, Non-Small-Cell Lung
1176
Prostatic Neoplasms
740
Colorectal Neoplasms
685
Neoplasm Metastasis
623
Multiple Myeloma
546
Melanoma
527
Ovarian Neoplasms
455
Lung Neoplasms
446
Lymphoma, Non-Hodgkin
385
Lymphoma
374
Recurrence
371
Leukemia, Myeloid, Acute
370
Pancreatic Neoplasms
358
Carcinoma, Renal Cell
339
Carcinoma, Hepatocellular
286
Stomach Neoplasms
281
Leukemia, Lymphocytic, Chronic, B-Cell
268
Lymphoma, Follicular
253
Head and Neck Neoplasms
246
Glioblastoma
219
Leukemia
215
Small Cell Lung Carcinoma
183
Lymphoma, Large B-Cell, Diffuse
182
Squamous Cell Carcinoma of Head and Neck
181
Carcinoma
175
Uterine Cervical Neoplasms
174
Urinary Bladder Neoplasms
174
Advanced Solid Tumors
160
Interventions
enzalutamide
1
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
INDUSTRY
×
Biochemically Recurrent Prostate Cancer
×
Clear all
NCT05526248
2026-03-11
ARAMON
Bayer
Phase 2
Completed
28 enrolled
14 charts